WET AMD MODELS
The most promising pipelines call for the best Wet AMD models.
Age-Related Macular Degeneration (AMD) has a global prevalence of around 170 million. Wet AMD, as opposed to dry AMD, exhibits vascular involvement which greatly exacerbates the pathological process of the disease. Only 10-15% of cases of AMD are wet, and while it is the more severe form, it can be treated.
AMD is one of the world’s top 7 causes of blindness and visual impairment. At PharmaLegacy, we believe that this needs to change. Were we to join efforts, with our models and your pipeline, AMD might one day lose its spot on the world’s leading causes of visual impairment and blindness.
MODELS / SERVICES
Start your dosing as soon as next week.
The DL-AAA induced RNV needs about 8~11 weeks to mature and stabilize, With hundreds of induced DL-AAA rabbits in-house, we save you up to three months of precious time.
Licensed from Jackson Lab and internal breeding already rolling, this JR5558 spontaneous CNV model in mouse closely mimics CNV development without laser induction, which is a perfect alternative of laser CNV model or subretinal fibrosis model.
PharmaLegacy is the first CRO to offer this unique model.
Tackling subretinal fibrosis secondary to CNV is critical to improve prognosis and long term treatment outcome. With persistent subretinal fibrosis and vasculature inside fibrotic lesion, this model offers much better window for anti-fibrosis therapeutic interventions alongside CNV.
Where pharmacology meets excellence:
- AAALAC and CNAS guidelines-adherent animal studies
- 24/7 access to PharmaLegacy representatives
- Completed over 600 FDA / CFDA IND filings
- FDA Part 11 compliant
Over half of the top 20 pharmaceutical companies can’t be wrong. Choose PharmaLegacy.
Top Pharmaceutical Companies Trust PharmaLegacy For Their Preclinical Ophthalmology Studies
Your preclinical ophthalmology studies call for flawless and affordable ophthalmology models. Download our Ophthalmology brochure and see how our models and decades of expertise can give you the clarity you need in your pipeline.
We’re ready when you are.
Tell us your pharmacology challenges & start your wet AMD study in as little as 2 weeks!
